Principal Securities’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.47M Sell
33,514
-7,632
-19% -$681K 0.04% 372
2026
Q1
$2.96M Buy
41,146
+1,253
+3% +$96.5K 0.04% 367
2025
Q4
$3.17M Buy
39,893
+4,956
+14% +$391K 0.05% 331
2025
Q3
$2.63M Buy
34,937
+3,070
+10% +$210K 0.04% 371
2025
Q2
$2.2M Buy
31,867
+3,862
+14% +$253K 0.04% 387
2025
Q1
$1.26M Buy
28,005
+124
+0.4% +$7.42K 0.03% 475
2024
Q4
$1.25M Buy
27,881
+859
+3% +$48.2K 0.03% 473
2024
Q3
$1.7M Sell
27,022
-23,793
-47% -$1.39M 0.04% 395
2024
Q2
$3M Buy
50,815
+5,284
+12% +$331K 0.08% 229
2024
Q1
$3.63M Buy
45,531
+4,546
+11% +$347K 0.11% 173
2023
Q4
$3.24M Buy
+40,985
New +$2.92M 0.12% 168

Other funds holding CVS

Principal Securities's CVS Position: Q2 2026 in Review

Principal Securities reduced its CVS Health (CVS) stake by 19% in Q2 2026, selling an estimated $681K and leaving 33,514 shares worth $3.47M. The position accounts for 0.04% of the portfolio, ranked #372.

Principal Securities first reported a position in CVS in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.63M in Q1 2024. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Principal Securities held 33,514 shares of CVS Health worth $3.47M as of Q2 2026.
  • Principal Securities sold 7,632 CVS Health shares in Q2 2026, an estimated $681K.
  • CVS Health made up 0.04% of Principal Securities's portfolio in Q2 2026, its #372 holding.
  • Principal Securities first reported a position in CVS Health in Q4 2023 and has held it in 11 quarters since.
  • Principal Securities's CVS Health position peaked at $3.63M in Q1 2024.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.